DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Dexamethasone sodium phosphateis the generic ingredient in thirteen branded drugs marketed by Ucb Inc, Merck, Cent Pharms, Abraxis Pharm, Fresenius Kabi Usa, Akorn, Amneal, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Dr Reddys, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Somerset, Somerset Theraps Llc, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Aspen Global Inc, Pharmafair, Alcon, Sola Barnes Hind, Bausch And Lomb, Sandoz Inc, and Alcon Pharms Ltd, and is included in fifty-four NDAs. Additional information is available in the individual branded drug profile pages.
There are thirty-nine drug master file entries for dexamethasone sodium phosphate. Seventeen suppliers are listed for this compound.
Summary for dexamethasone sodium phosphate
Recent Clinical Trials for dexamethasone sodium phosphate
Identify potential brand extensions & 505(b)(2) entrants
|Weill Medical College of Cornell University||Phase 1|
|OHSU Knight Cancer Institute||Phase 2|
|Oregon Health and Science University||Phase 2|
Pharmacology for dexamethasone sodium phosphate
|Drug Class||Corticosteroid |
|Mechanism of Action||Corticosteroid Hormone Receptor Agonists |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Merck||DECADRON||dexamethasone sodium phosphate||INJECTABLE;INJECTION||012071-004||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Merck||DECADRON||dexamethasone sodium phosphate||SOLUTION/DROPS;OPHTHALMIC, OTIC||011984-001||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Amneal||DEXAMETHASONE SODIUM PHOSPHATE||dexamethasone sodium phosphate||INJECTABLE;INJECTION||208689-001||Aug 22, 2018||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Merck||DECADRON||dexamethasone sodium phosphate||INJECTABLE;INJECTION||012071-002||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Alcon||MAXIDEX||dexamethasone sodium phosphate||OINTMENT;OPHTHALMIC||083342-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.